Related Experiment Video
Updated: Sep 7, 2025

14:20
Polymalic Acid-based Nano Biopolymers for Targeting of Multiple Tumor Markers: An Opportunity for Personalized Medicine?
Published on: June 13, 2014
16.8K
Polymalic acid for translational nanomedicine.
Xing Huang1, Liusheng Xu2, Hui Qian2,3
1Center for Evidence-Based and Translational Medicine, Department of Urology, Zhongnan Hospital of Wuhan University, Wuhan, 430071, Hubei, China.
Journal of Nanobiotechnology
|June 21, 2022
Summary
Biodegradable polymalic acid (PMLA) shows promise as a nanocarrier for drug delivery and diagnostics. Research explores its biosynthesis, functionalization, and potential in clinical nanomedicine.
Area of Science:
- Biomaterials Science
- Polymer Chemistry
- Nanomedicine
Background:
- Biodegradable polymalic acid (PMLA) possesses abundant carboxyl groups, making it suitable for drug delivery.
- PMLA can be synthesized chemically or biologically through microbial fermentation.
- It serves as a versatile nanoscale carrier for pharmaceutical agents.
Purpose of the Study:
- To review the biosynthesis, biodegradation, and characterization of PMLA.
- To compare chemical and biological synthesis methods for PMLA production.
- To discuss PMLA's potential as a drug delivery carrier for diagnosis and therapy.
Main Methods:
- Literature review of PMLA biosynthesis and chemical synthesis.
- Analysis of PMLA biodegradation mechanisms and characterization techniques.
- Examination of PMLA functionalization strategies for biomedical applications.
Main Results:
- PMLA can be produced via microbial fermentation and characterized using established analytical methods.
- Functionalized PMLA acts as a nanoscale carrier for active pharmaceutical molecules.
- The review discusses PMLA's advantages, disadvantages, and current challenges in nanomedicine.
Conclusions:
- PMLA is a promising biodegradable polymer for multifunctional nanomedicine applications.
- Further research is needed to overcome challenges in PMLA's clinical translation.
- PMLA holds significant potential for future advancements in targeted therapy and imaging diagnosis.

